[HTML][HTML] Added value of respiratory gating in positron emission tomography for the clinical management of lung cancer patients

W Grootjans, DDD Rietbergen… - Seminars in nuclear …, 2022 - Elsevier
Positron emission tomography (PET) is an important imaging modality for personalizing
clinical management of patients with lung cancer. In this regard, PET imaging is essential for …

Volumetric parameters from [18F]FDG PET/CT predicts survival in patients with high‐grade gastroenteropancreatic neuroendocrine neoplasms

H Langen Stokmo, M Aly… - Journal of …, 2022 - Wiley Online Library
Abstract A positive fluorine‐18 labelled 2‐deoxy‐2‐fluoroglucose ([18F] FDG) positron
emission tomography/computed tomography (PET/CT) has been associated with more …

[HTML][HTML] Predictive value of baseline metabolic tumor burden on 18F-FDG PET/CT for brain metastases in patients with locally advanced non-small-cell lung cancer

J Shang, H You, C Dong, Y Li, Y Cheng, Y Tang… - Frontiers in …, 2022 - frontiersin.org
Objectives Brain metastases (BMs) are a major cause leading to the failure of treatment
management for non-small-cell lung cancer (NSCLC) patients. The purpose of this study …

Glucose metabolic heterogeneity correlates with pathological features and improves survival stratification of resectable lung adenocarcinoma

YH Chen, YC Chen, KH Lue, SC Chu… - Annals of Nuclear …, 2023 - Springer
Objective We investigated whether glycolytic heterogeneity correlated with histopathology,
and further stratified the survival outcomes pertaining to resectable lung adenocarcinoma …

[HTML][HTML] Prognostic Value of Combing Primary Tumor and Nodal Glycolytic–Volumetric Parameters of 18F-FDG PET in Patients with Non-Small Cell Lung Cancer and …

YH Chen, SC Chu, LY Wang, TF Wang, KH Lue, CB Lin… - Diagnostics, 2021 - mdpi.com
We investigated whether the combination of primary tumor and nodal 18F-FDG PET
parameters predict survival outcomes in patients with nodal metastatic non-small cell lung …

[HTML][HTML] Tumor metabolic and secondary lymphoid organ metabolic markers on 18F-fludeoxyglucose positron emission tomography predict prognosis of immune …

P Jin, M Bai, J Liu, J Yu, X Meng - Frontiers in Immunology, 2022 - frontiersin.org
Background The purpose of this study was to investigate the predictive value of tumor
metabolic parameters in combination with secondary lymphoid metabolic parameters on …

[HTML][HTML] Evaluation of therapeutic effect and prognostic value of 18F-FDG PET/CT in different treatment nodes of DLBCL patients

W Zhao, X Wu, S Huang, H Wang, H Fu - EJNMMI research, 2024 - Springer
Background In the present study, we aimed to investigate the role of baseline (B), interim (I)
and end-of-treatment (Eot) 18F-FDG PET/CT in assessing the prognosis of diffuse large B …

Deep Learning Features and Metabolic Tumor Volume Based on PET/CT to Construct Risk Stratification in Non-small Cell Lung Cancer

L Ju, W Li, R Zuo, Z Chen, Y Li, Y Feng, Y Xiang… - Academic …, 2024 - Elsevier
Rationale and Objectives To build a risk stratification by incorporating PET/CT-based deep
learning features and whole-body metabolic tumor volume (MTV wb), which was to make …

[HTML][HTML] Coefficient of Variation in Metastatic Lymph Nodes Determined by 18F-FDG PET/CT in Patients with Advanced NSCLC: Combination with Coefficient of …

S Pellegrino, R Fonti, C Vallone, R Morra, E Matano… - Cancers, 2024 - mdpi.com
Simple Summary Lung cancer is the leading cause of cancer-related death worldwide. The
18F-FDG PET/CT scan is used daily for the diagnosis and staging of lung cancer. The …

[HTML][HTML] Machine Learning and Texture Analysis of [18F]FDG PET/CT Images for the Prediction of Distant Metastases in Non-Small-Cell Lung Cancer Patients

A Hakkak Moghadam Torbati, S Pellegrino, R Fonti… - Biomedicines, 2024 - mdpi.com
The aim of our study was to predict the occurrence of distant metastases in non-small-cell
lung cancer (NSCLC) patients using machine learning methods and texture analysis of 18F …